Hurrah! It's holiday time!
I'm off with my family for a road trip around California from mid-July. Awwww. Missing you too. I don't personally expect to get up to much trading this summer as our market will be nearly closed by the time I wake up in the US.
It's always hard when you're on holiday, but generally it is probably best to have stop losses with most trades because at least then your capital won't be totally slaughtered by unexpected events while you are on holiday.
However don't miss me too much as there are hundreds of pages of good stuff to read from me as the new edition of my book "Naked Trader" has just been published!
You can only get Naked Trader 4 from my website for the time being and the first 500 copies ordered get a free packet of Naked Trader T- Bags!
The book updates Naked Trader 3 which I wrote in 2011 - a lot has happened in the market since then and I cover all the changes.
There are tons of ideas, trader stories, psychology, biggest trading mistakes and 20 trading strategies to make money. Also loads of stuff I have learned over the last three years.
New insights into trading tax free, tons of examples, a whole load of new traders' tales... look, don't be tight, just buy it!
To get Naked Trader 4 click the link at my website www.nakedtrader.co.uk.
There are some interesting companies that have recently come down 30% or more off their highs. That is, quality companies that have been hit for I think temporary reasons and so I've been snapping some of these up expecting to hold them over the summer while they recover.
So here is my list of potential summer recover play sizzlers!
1. Telecom Plus
This one has fallen a long way from its high but looks a great one to snap up near recent lows for potential big returns. It provides utilities, phone and broadband services sold by independent distributors. The company reckons profits will be up to £63m soon, a big jump. There's a nice dividend too. Customer service is highlighted as excellent by Which magazine and the company is bullish on its prospects after recently buying its energy customers from N Power enabling it to ensure a leap in profits. Especially if this ends up being a cold winter, watch for massive gains by next summer. Probable long-term winner from near lows.
Well, I'm sure you all know what Asos does - sells clothes on the internet. It was the darling of the market till recently and it has more than halved quite quickly. The rate of fall is stopping and it looks like it is getting time to buy what is a brilliant company somewhere near a likely low for a long time. A rise in Sterling did some of the damage, that won't last foreever - and with its strong brand and cash generation, this looks like a perfect buy for great gains to come. It had a warehouse fire but that was a good excuse to buy at a great price.
Cloud computing group Iomart looks very cheap after coming back quite a bit from highs. It is considered a high tech share but they are not on a massive tech rating and at least there are real profits which are climbing sharply. Indeed I thought its recent statement was excellent with adjusted profit before tax growth of a very decent 37%. With a dividend up 25% and a company that is generating good cash flow, looks a great time to get in.
This previous high flyer has just been hit by a profits warning. Xaar is a digital inkjet printing company that could previously do no wrong. But management warned revenues are going to be lower for now. However, the market looks to the future and that eventually looks bright with a lot of new products about to hit the market and it expects revenues to flow from those in the second half of the year so I reckon a good time to get in while it is weak before these come through.
A drugs company well down from its highs giving investors the chance to get in at a great price as its future is solid. It has a superb pipeline of drugs. It specialises in drugs and inhalers to help those with airways related diseases. It has partnerships with all the main drug distributors and has got a £10m payment from Glaxo. A lot of its drugs and products have been picking up approvals in various countries so this one looks a potential giant in the making and at this price well off its highs it looks one to pick up.